Eli Lilly has the benefit currently, claims the Barclays expert.
发布者：BY CHRISTIAN BUNDGAARD，转转请注明出处：https://robotalks.cn/analyst-novo-nordisk-has-a-credibility-problem-2/
关于作者
Three pharmaceutical companies show up for price negotiations
上一篇
26 1 月, 2025 11:18 上午
Leo Pharma could be overrun by competitors in market for eczema drugs
下一篇
26 1 月, 2025 11:18 上午
相关推荐
-
Freegold drills strong wide intercepts in Alaska
Freegold Ventures (TSX: FVL) has actually reported even more piercing success from its Golden Top job in Alaska where it’s specifying a starter pit in the lead approximately …
-
“Wearable” devices for cells
Wearable tools like smartwatches and health and fitness trackers engage with components of our bodies to determine and pick up from interior procedures, such as our heart price or …
-
令和の販売員心得 黒川想介 （119）「全自動」を夢見たFA黎明期 意気込みなくなり効率重視へ
現在、隆盛を誇っているFAマーケットではオートメーションという言葉を使った会話は皆無である。しかしFAマーケットの黎明期にはオートメーションという言葉をよく使った。その言葉には夢があった。製造現場でオートメ化が進めば将来は全ての機械設備は自動で動き、 […]
-
French startup SURGAR raises €11 million to deploy AR for minimally invasive surgery
Clermont-Ferrand-based SURGAR, a start-up creating increased truth options for minimally intrusive surgical procedure, is enjoyed reveal the closing of an EUR11 million financing r…
-
MIT researchers develop an efficient way to train more reliable AI agents
Area varying from robotics to medication to government are trying to educate AI systems to make purposeful choices of all kinds. For instance, utilizing an AI system to smartly reg…
